Towards a definition of refractory neuropathic pain for epidemiological research. An international Delphi survey of experts

Abstract

BackgroundBest current estimates of neuropathic pain (NeuP) prevalence come from studies using various screening detecting pain with probable neuropathic features; the proportion experiencing significant, long-term NeuP, and the proportion not responding to standard treatment are unknown. These “refractory” cases are the most clinically important to detect, being the most severe, requiring specialist treatment.MethodsWe report an international Delphi survey of experts in NeuP, aiming for consensus on the features required to define, for epidemiological research: (1) neuropathic pain; and (2) when NeuP is “refractory”. A web-based questionnaire was developed and data collected from three rounds of questionnaires from nineteen experts.ResultsThere was good consensus on essential inclusion of six items to identify NeuP (“prickling, tingling, pins & needles”, “pain evoked by light touch”, “electric shocks or shooting pain”, “hot or burning” pain, “brush allodynia on self-examination”, and “relevant history”) and on some items that were non-essential. Consensus was also reached on components of a “refractory NeuP” definition: minimum duration (one year); number of trials of drugs of known effectiveness (four); adequate duration of these trials (three months / maximum tolerated); outcomes of treatment (pain severity, quality of life). Further work needs to validate these proposed criteria in general population research.ConclusionsThis paper presents an international consensus on measuring the epidemiology of refractory neuropathic pain. This will be valuable in reaching an agreed estimate of the prevalence of neuropathic pain, and the first estimate of refractory neuropathic pain prevalence.

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study

“…The lack of specific validation can be considered a limitation of this study. However, in the last few years there is an increasing number of international studies, that furthermore use the on-line way of experts voting, as an effective tool for international collaboration [34][35][36][37][38].…”

Palliative Care for Severely Affected Patients with Multiple Sclerosis: When and Why? Results of a Delphi Survey of Health Care Professionals

“…17 The method has been widely and effectively used in medical and nursing research and is also common in palliative care. [18][19][20] This approach provides the participants in the second round with the results of the first so that they can alter their original assessments if they so desire or stand by their previous opinion. Independent objectivity is ensured because the…”

Pharmacoresistant neuropathic pain: Role of proper assessment in the understanding and tactics of correction

“…Это позволяет оценить масштаб данной проблемы, выде-лить факторы риска формирования резистентности болево-го синдрома к фармакотерапии (включая потенциально мо-дифицируемые факторы) и разработать новые методы лече-ния или стратегии профилактики. Согласно международно-му Дельфийскому опросу экспертов, ФНБ (в эпидемиоло-гических исследованиях) определяют по следующим крите-риям [23] 2) продолжительность лечения каждым из этих препаратов ≥3 мес или прекращение лечения из-за побочных эффек-тов; 3) снижение интенсивности боли на ≤30% или ее ин-тенсивность на уровне ≥5 баллов по 10-балльной ВАШ ли-бо продолжительный болевой синдром, приводящий к су-щественному ухудшению качества жизни. В исследовании N. Torrance и соавт.…”

“…К данной группе нередко относят паци-ентов, которым не проводится адекватная терапия в соот-ветствии с международными рекомендациями, не соблюда-ются сроки лечения, дозы и кратность приема лекарствен-ных средств. Определение ФНБ следует давать согласно ме-ждународному Дельфийскому опросу экспертов [23], что позволит выбрать правильную тактику лечения.…”